Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Veit-Haibach

Showing results (111-120 of 220) with videos related to

Pageof 22
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|January 13, 2012
SPECT/CT versus MRI in patients with nonspecific pain of the hand and wrist - a pilot studyMartin W Huellner, Alexander Bürkert, Florian S Schleich, et al.
European Journal of Radiology|December 25, 2007
Comparison of FDG-PET, PET/CT and MRI for follow-up of colorectal liver metastases treated with radiofrequency ablation: initial resultsHilmar Kuehl, Gerald Antoch, Hrvoje Stergar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 16, 2008
Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancerKlaus Strobel, Stefan Heinrich, Ujwal Bhure, et al.
Abdominal Imaging|July 14, 2009
Feasibility of integrated CT-liver perfusion in routine FDG-PET/CTPatrick Veit-Haibach, Valerie Treyer, Klaus Strobel, et al.
Cancers|December 23, 2022
CT Radiomics and Whole Genome Sequencing in Patients with Pancreatic Ductal Adenocarcinoma: Predictive Radiogenomics ModelingRicarda Hinzpeter, Roshini Kulanthaivelu, Andres Kohan, et al.
Investigative Radiology|April 9, 2014
Assessment of prostate cancer with dynamic contrast-enhanced computed tomography using an en bloc approachMartin W Huellner, Chantal Pauli, Agostino Mattei, et al.
Nuclear Medicine Communications|October 16, 2024
Combination of FDG PET/CT radiomics and clinical parameters for outcome prediction in patients with non-Hodgkin's lymphomaClaudia Ortega, Reut Anconina, Sayali Joshi, et al.
Cancers|November 25, 2023
Impact of the COVID-19 Pandemic on Staging Oncologic PET/CT Imaging and Patient Outcome in a Public Healthcare Context: Overview and Follow Up of the First Two Years of the PandemicAndres Kohan, Sumesh Menon, Vanessa Murad, et al.
Langenbeck'S Archives of Surgery|January 7, 2022
The clinical consequences of functional adrenal uptake in the absence of cross-sectional mass on FDG-PET/CT in oncology patientsRalph Hsiao, Alicia Chow, Wouter P Kluijfhout, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 22, 2009
Diagnostic accuracy of contrast-enhanced FDG-PET/CT in primary staging of cutaneous malignant melanomaPatrick Veit-Haibach, Florian M Vogt, Robert Jablonka, et al.
Pageof 22

Showing results (111-120 of 220) with videos related to

Sort By:
Pageof 22
European Journal of Nuclear Medicine and Molecular Imaging|January 13, 2012
SPECT/CT versus MRI in patients with nonspecific pain of the hand and wrist - a pilot studyMartin W Huellner, Alexander Bürkert, Florian S Schleich, et al.
European Journal of Radiology|December 25, 2007
Comparison of FDG-PET, PET/CT and MRI for follow-up of colorectal liver metastases treated with radiofrequency ablation: initial resultsHilmar Kuehl, Gerald Antoch, Hrvoje Stergar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 16, 2008
Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancerKlaus Strobel, Stefan Heinrich, Ujwal Bhure, et al.
Abdominal Imaging|July 14, 2009
Feasibility of integrated CT-liver perfusion in routine FDG-PET/CTPatrick Veit-Haibach, Valerie Treyer, Klaus Strobel, et al.
Cancers|December 23, 2022
CT Radiomics and Whole Genome Sequencing in Patients with Pancreatic Ductal Adenocarcinoma: Predictive Radiogenomics ModelingRicarda Hinzpeter, Roshini Kulanthaivelu, Andres Kohan, et al.
Investigative Radiology|April 9, 2014
Assessment of prostate cancer with dynamic contrast-enhanced computed tomography using an en bloc approachMartin W Huellner, Chantal Pauli, Agostino Mattei, et al.
Nuclear Medicine Communications|October 16, 2024
Combination of FDG PET/CT radiomics and clinical parameters for outcome prediction in patients with non-Hodgkin's lymphomaClaudia Ortega, Reut Anconina, Sayali Joshi, et al.
Cancers|November 25, 2023
Impact of the COVID-19 Pandemic on Staging Oncologic PET/CT Imaging and Patient Outcome in a Public Healthcare Context: Overview and Follow Up of the First Two Years of the PandemicAndres Kohan, Sumesh Menon, Vanessa Murad, et al.
Langenbeck'S Archives of Surgery|January 7, 2022
The clinical consequences of functional adrenal uptake in the absence of cross-sectional mass on FDG-PET/CT in oncology patientsRalph Hsiao, Alicia Chow, Wouter P Kluijfhout, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 22, 2009
Diagnostic accuracy of contrast-enhanced FDG-PET/CT in primary staging of cutaneous malignant melanomaPatrick Veit-Haibach, Florian M Vogt, Robert Jablonka, et al.
Pageof 22